Direct Observation Therapy - Gibrilla Story

10-year-old Gibrilla at the MSF DOT site at Kamaranka, Bombali District, being consulted by MSF medical outreach team.

Gibrilla is currently on his second month of treatment for Drug Sensitive TB (DR-TB).

As part of its strategy to combat TB, the MSF team in Bombali District has flagged 12 DOT sites and the medical outreach team visits every DOT site once a week to screen patients, collect samples for testing, administer treatment and do referrals.

MSB152670

To Report An Asset

If you think this image is in any way inappropriate, please report it, by including its URN/identifying code and a brief description of your concern in sending an email to [email protected]

Linked assets

PDF

CONSENT FORM - Yanenneh Bangara and Gibrilla Kamara

World TB Day 2023 - PHOTO

Add to lightbox

Add to cart

Unique Identifier Code / URN MSB152670

Date taken / Date Recorded 27/01/2023 12:20 PM

Country Sierra Leone

Commissioning section MSF-NETHERLANDS

Photographer / videographer / producer Mary Dumbuya

Copyright Mary Dumbuya/MSF

Usage Rights (MSF) External Media, MSF Fundraising, MSF Publications, Social Media

Formal Consent Copy available yes

Editor's rating ★★★ (F)

Maximum Size 6016px × 4016px 11.98 MB

Additional Information / Shotlist MSF has been supporting the Ministry of Health and Sanitation in Makeni Regional hospital with the diagnosis and treatment of DR-TB since 2019. The MSF TB centre screens and diagnoses patients with DR-TB. Patients were placed on the 9-month or the 18-month regimens.

In October 2022, MSF together with National Leprosy and Tuberculosis Control Program (NLTCP) started introducing the BPaLM regimens, a WHO-recommended, six-month long all-oral treatment for DR-TB. With the new regimen, patients are taking less medicines, have fewer side effects and are treated within a much shorter time.